
GLP-1 Receptor Agonist · Prescription required
Compounded Semaglutide
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used in medically supervised weight-management care for adults who meet specific clinical criteria. An independent licensed provider may prescribe a compounded formulation when clinically appropriate.
Pharmacy & Regulatory Notice: Compounded semaglutide is prepared for an individual patient by Rush Pharmacy or Epiq Scripts, state-licensed compounding pharmacies, pursuant to a valid prescription. Compounded medications are not FDA-approved, meaning the FDA has not reviewed them for safety, effectiveness, or quality. Compounded semaglutide is not manufactured by or affiliated with Novo Nordisk A/S.
Learn About Compounded Semaglutide →